CCAP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Crescent Capital BDC Inc (CCAP) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock shows a neutral technical setup and lacks significant positive catalysts, its recent financial performance is concerning, and there are no strong signals or favorable trends to justify immediate investment. Holding off for now is recommended.
The MACD is slightly positive, indicating mild bullish momentum, but the RSI is neutral at 49.544, showing no clear trend. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its pivot level of 13.116. Key resistance levels are at 13.521 and 13.771, while support levels are at 12.711 and 12.461.
No recent news or significant positive catalysts. The stock has a 4.76% chance of increasing in the next month based on historical patterns.
The company's financial performance in Q4 2025 was poor, with revenue dropping by -99.84% YoY and EPS declining by -14.81% YoY. Gross margin also fell drastically. Analysts have lowered the price target from $14 to $13, reflecting cautious sentiment.
In Q4 2025, revenue dropped significantly (-99.84% YoY), net income declined by -15.02% YoY, and EPS fell by -14.81% YoY. Gross margin was negative, indicating severe financial challenges.
Wells Fargo analyst Finian O'Shea downgraded the price target to $13 from $14 and maintained an Equal Weight rating, reflecting cautious optimism about potential fee and dividend revisions.
